4400万美元买断阿尔兹海默症新药 康哲药业能否抢滩成功?

21世纪经济报道
09 Jan

卖药大户康哲药业(00867.HK)拿下了一个“潜在爆品”。1月8日,康哲药业宣布,通过全资附属公司与Alpha Cognition就用于治疗轻度至中度阿尔茨海默型痴呆症状的改良型新药ZUNVEYL签订许可、合作与经销协议。根据预计,2035年,中国60岁及以上人口至少增加40%。随着老龄化的到来,阿尔茨海默病也迎来爆发风险。老年痴呆一般指阿尔茨海默病,也被称为“脑海中的橡皮擦”,会出现记忆力下降...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10